Health News
Date: Oct-09-2012
Snoring, independent of sleep apnea, is not a risk factor for mortality or cardiovascular disease, according to Australian researchers at the Woolcock Institute of Medical Research. In their world-first study, the experts determined that individuals who snored the majority of the night were not more likely to die within the next 17 years than those who snored a mere 12% of the night or less...
Date: Oct-09-2012
Researchers from the National Institutes of Health (NIH) in the US have conducted a study about a new magnetic resonance imaging (MRI) technique that may soon be used to identify the early stages of coronary heart disease (CAD), the most common form of heart disease. They write about the new technique, which can identify thickening of the coronary artery wall, in a paper expected to be published early online in the journal Radiology this week...
Date: Oct-09-2012
According to the authors of a new editorial published early online in Annals of Internal Medicine, the new over-the-counter, home-based HIV test, OraQuick, is not likely to lower the barriers to care or reduce HIV transmission. With its relatively high cost, the test is likely to attract affluent persons at low risk for infection, persons with very recent high-risk exposures, or those with diagnosed HIV seeking to find out if treatment has reversed their seropositivity...
Date: Oct-09-2012
Researchers from The George Washington University published a study showing that breast cancer patients can reduce potentially dangerous delays in the identification of breast cancer with the assistance of patient navigation services. Patient navigation - a service that helps patients overcome barriers to getting health care, including setting up appointments, dealing with health insurance, and helping with fears about cancer - led to a nearly four-fold reduction in the time it took to diagnose a suspicious breast lump, the new study found...
Date: Oct-09-2012
Researchers at the RIKEN Center for Genomic Medicine (CGM) and their colleagues have identified 8 new loci associated with susceptibility to atopic dermatitis in the Japanese population. The findings, which appear in the journal Nature Genetics, advance our understanding of the genetic basis of the skin disorder, which affects millions of children and adults around the world. Atopic dermatitis (often called ecszema) is a chronic, relapsing inflammatory skin condition affecting as much as one-fifth of children and 1-3% of adults in industrialized countries...
Date: Oct-09-2012
Ferrer, a privately-held Spanish pharmaceutical company with full vertical integration from R&D to distribution, has announced that it has successfully completed an absorption, tolerability and safety clinical trial in adult and juvenile patients from two months of age with impetigo involving Ozenoxacin formulated as a topical treatment for infectious dermatological conditions...
Date: Oct-09-2012
For patients that risk severe anaphylactic reactions from food, even the simpliest actions in daily life, such as eating at a restaurant or purchasing food sold in a marketplace can be life-threatening as 7 out of 10 severe reactions happen when eating out...
Date: Oct-09-2012
UCLA researchers have for the first time measured the activity of a brain region known to be involved in learning, memory and Alzheimer's disease during sleep. They discovered that this part of the brain behaves as if it's remembering something, even under anesthesia, a finding that counters conventional theories about memory consolidation during sleep. The research team simultaneously measured the activity of single neurons from multiple parts of the brain involved in memory formation...
Date: Oct-09-2012
Ask adults from the industrialized world what number is halfway between 1 and 9, and most will say 5. But pose the same question to small children, or people living in some traditional societies, and they're likely to answer 3. Cognitive scientists theorize that that's because it's actually more natural for humans to think logarithmically than linearly: 30 is 1, and 32 is 9, so logarithmically, the number halfway between them is 31, or 3. Neural circuits seem to bear out that theory...
Date: Oct-09-2012
Bristol-Myers Squibb have announced that the European Commission has granted marketing authorisation for the subcutaneous formulation of ORENCIA® (abatacept), in combination with methotrexate (MTX), for the treatment of adults with moderate to severe active rheumatoid arthritis (RA). Most of the currently available biologics for the treatment of RA are anti-TNF (anti-tumour necrosis factor) agents...